PRESS RELEASE published on 03/07/2024 at 07:00, 8 months 14 days ago Evolva Holding SA in liquidation: Nice & Green requests 3 agenda items be included in AGM agenda Evolva Holding SA in liquidation receives requests for 3 agenda items at AGM from shareholder Nice & Green SA; shareholder Pegasus Global Opportunity Fund Ltd crosses 10% threshold Shareholders AGM Evolva Holding SA Nice & Green SA Pegasus Global Opportunity Fund Ltd
PRESS RELEASE published on 09/28/2023 at 07:00, 1 year 1 month ago Evolva and LEHVOSS sign agreement for distribution of Veri-teTM Resveratrol in over a dozen European countries
PRESS RELEASE published on 09/13/2023 at 07:00, 1 year 2 months ago Evolva and Nice & Green agree on improvements to financing agreement
PRESS RELEASE published on 09/06/2023 at 07:00, 1 year 2 months ago Evolva receives approval for Veri-teTM Resveratrol in Thailand
PRESS RELEASE published on 08/24/2023 at 20:00, 1 year 2 months ago Evolva shareholders approve increase of the conditional capital and upper limit of capital band at extraordinary general meeting of 24 August 2023
PRESS RELEASE published on 08/24/2023 at 07:00, 1 year 2 months ago Evolva with good business momentum and significant progress in profitability in 1H 2023, despite major financing challenges
PRESS RELEASE published on 07/28/2023 at 07:00, 1 year 3 months ago Evolva Holding SA: Evolva convenes extraordinary general meeting (EGM) for 24 August 2023 to secure financing until end of the year
PRESS RELEASE published on 07/25/2023 at 07:00, 1 year 3 months ago Evolva receives approval for Veri-teTM Resveratrol in Taiwan
PRESS RELEASE published on 06/26/2023 at 07:00, 1 year 4 months ago Evolva Holding SA: Evolva signs agreement with Nice & Green to secure financing at least until the end of 2023, continues to pursue strategic alternatives
PRESS RELEASE published on 06/14/2023 at 07:00, 1 year 5 months ago Evolva informs about renegotiation of financing arrangement, initiates review of strategic alternatives and revokes guidance
Published on 11/21/2024 at 14:30, 30 minutes ago Xenetic Biosciences, Inc. Presents Positive Preclinical Data Highlighting the Potential of Co-Administration of DNase I with CAR T Cells in a Murine Model of Melanoma Lung Metastasis
Published on 11/21/2024 at 14:30, 30 minutes ago Sarama Announces Equity Placement of Up to A$2M and Issue of Equity for Debt
Published on 11/21/2024 at 14:15, 45 minutes ago neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 1 hour ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 1 hour ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:16, 43 minutes ago EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 45 minutes ago ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 13:41, 1 hour 19 minutes ago Original-Research: Pentixapharm Holding AG (von BankM AG): Kaufen
Published on 11/21/2024 at 06:58, 8 hours 2 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 8 hours 2 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 8 hours 2 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 18 hours 52 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 19 hours 40 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
